Mycophenolate Mofetil 500 mg/1

Mycophenolate mofetil 500 mg tablets are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Accord Healthcare Inc. in the USA.

Mycophenolate mofetil is primarily used to prevent rejection in patients who have received a kidney, heart, or liver transplant. It works by weakening the immune system to help the body accept the new organ. This medication is often prescribed as part of a broader treatment plan that may include other immunosuppressants.

Common effects of mycophenolate mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some users may also experience fatigue, headache, or an increased risk of infections due to its impact on the immune system. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Mycophenolate mofetil should be handled with care, as it can increase the risk of infections and other serious side effects. It is important to follow the prescribed dosage and avoid activities that may compromise immune function. Regular blood tests may be required to monitor for potential complications.

Mycophenolate mofetil may interact with other medications, including certain antibiotics, antivirals, and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.